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Standards in Dermatologic Imaging
Ashfaq A. Marghoob, MD; for the International Skin Imaging CollaborationMelanoma Project Working Groups
The current era of ubiquitous digital cameras, digital cameras
integrated into smartphones, and virtually limitless data stor-
age affords exciting newopportunities formedicine in general
and specifically dermatol-
ogy. Digital photography has
the potential to dramatically
enableandfacilitate improve-
ments indermatologyteaching,clinicaldocumentation,anddi-
agnosis. One of the barriers to the diffusion of digital imaging
intodermatologypractice is the lackofstandards fordigitalpho-
tography.Asnoted in thearticlebyQuigleyet al,1 there are cur-
rently no standards for dermatologic photography designated
by Digital Imaging and Communications in Medicine. While
some organizations, such as the American Teledermatology
Association,2 have offered general guidelines, to our knowl-
edge, no consistent actionable standards exist inmedical pub-
lications. The absence of standards severely impedes the inte-
gration of dermatologic images across systems that support
documentation, diagnosis, and clinical practice.
In a white paper for the Digital Imaging and Communica-
tions in Medicine working group, Madden3 enumerates the
many challenges to the development and implementation of
dermatologic imaging standards. Foremost among these is the
typical relianceon consumeroff-the-shelf cameras andmoni-
tors for dermatologic imaging. Off-the-shelf technologies are
designed for consumer satisfaction rather than optimization
of clinically relevant imaging. The image processing algo-
rithms,whitebalance, andcolor calibrationusedby thesecam-
eras and monitors are inherently proprietary and continu-
ouslychanging. Inaddition to introducing technical limitations
and variability, reliance on off-the-shelf technology has im-
peded the establishment of a significant capital equipment
market in dermatologic imaging. As such, there are no ven-
dors who aremotivated to invest heavily in the development
and validation of dermatology-relevant standards across the
entire spectrum of image acquisition, storage, and display.
Today, patients routinely use “selfies” to communicate
with their physicians about lesions they are concerned about,
and they are also beginning touse selfies as ameans formoni-
toring nevi, a variety of skin eruptions, and ulcers. In addi-
tion, the widespread use of smartphones has spawned a
plethora of dermatology applications (“apps”), with new re-
leases being added to the ever-expanding apps list on a regu-
lar basis. Unfortunately, while the public has been quick to
adopt these trends, many dermatologists are still document-
ing their findings via text messaging. However, basic stan-
dards could go a longway toward improving theutility of der-
matologic photography.While adequate imagequalitymaybe
subjective anddiffer by theapplication (eg, diagnosis vsdocu-
mentation), a standard approach to image-associated meta-
data is needed to have interchangeable systems andmethods
for filtering images for quality assurance and control. A pre-
requisite for consistentmetadata is consistent terminology for
technical (eg, image type) and clinical (eg, anatomic site) data.
The common terminology shouldbe aligned as closely as pos-
sible with existing standards, such as Systematized Nomen-
clature ofMedicine Clinical Terms4 and Institute of Electrical
and Electronics Engineers standards.5
In theabsenceofexternal regulatoryandindustrydriversof
dermatology imaging standards, it behooves the dermatology
community towork toward theestablishment anddiffusionof
some basic standards. Failing to do so creates the risk ofmiss-
ingoutonthefullbenefitsof imagingforourpatientsandreflects
adverselyonourprofession.Despitemuchresistance fromphy-
sicians, it is clear that theelectronicmedical record ispermeat-
ingmedical practiceowing to requirements set forthby federal
and private health care payers. In the process of incorporating
a text-basedandmetadata–baseddocumentationsystem, con-
sidering theneedtoproperly reflect theelementsofanencoun-
ter to support the coding for a given visit, dermatologists and
othermedicalprofessionals spendasignificantportionof their
dailyclinicaleffort inmeetingtheseexpectations.Unfortunately,
standards to incorporate thevaluablepresenceofdigital images
into theelectronicmedical recordsystemdonothave thesame
level of interest and adoption. The accuracy of dermatological
findings documented through digital images far exceedswhat
eventhemostdetailedtextcanreflect.Establishingaconsistent
approachto imageacquisition, storage,andviewinghas thepo-
tential topreserve, in the long term, themostvaluableaspectof
amedical specialty that isbasedonvisualassessmentof thehu-
man skin. If the dermatology community fails to take a leader-
shiprole indefiningandsetting imagingstandards, there isarisk
that impracticalorspecialty-inappropriatestandardswillbe im-
posed by external organizations.
Anobviousapproach fordermatologyasa specialty is to le-
verage the effort already set forth by establishedmedical com-
munities. A series of radiologic standards onmedical imaging
as it relates to storage, security, and viewing has already been
established and could serve as a platform for skin-related
imagingstandardization.Withindermatology,establishedcom-
munities with shared clinical or research goals are best suited
to contribute to the evolution of standards. One such commu-
nity is themelanoma-dermoscopycommunity,acollegialgroup
with an impressive record of broad-based collaborative
research.6 In addition, an associated cottage industry of ven-
dorsof imaging technologyhas arisenaround this community.
Thiscommunityhasestablishedthe InternationalSkin Imaging
Collaboration (ISIC)under theauspicesof the International So-
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ciety forDigital Imaging of the Skin to address the unmet need
fordigital-imagingstandards.7The initial endeavorof ISIC is the
Melanoma Project, a collaborative effort between skin cancer
specialists (InternationalDermoscopySociety), informaticsex-
perts (IBM), and imaging technology developers (manufac-
tures of dermoscopes, cameras, lenses, and skin imaging sys-
tems). The overarching goal of the Melanoma Project is to
support efforts to reducemelanoma-relateddeathsandunnec-
essarybiopsiesbyimprovingtheaccuracyandefficiencyofearly
detection of melanoma.7 This project consists of the develop-
ment of skin imaging standards and the creation of a public ar-
chive of annotated and validated skin lesion images.
The optimal use of images for education, self-diagnosis,
telediagnosis, computer-assisteddiagnosis,patient triage,mole
monitoring,documentation, andcoordinationof carewill ben-
efit from thedevelopment of technology, techniques, and ter-
minologystandards.With this inmind, ISIChascreated3work-
ing groups charged with defining and creating a set of
standards. The TechnologyWorking Group’s responsibility is
to develop standards forminimum functional capabilities for
the equipment and settings used in the acquisition, process-
ing, compression, display, printing, archiving, retrieval, and
storage systems and to secure the transmissionof clinical and
dermoscopic images. TheTechniqueWorkingGroup’s respon-
sibility is to develop standards specifying minimum require-
ments for physical conditions thatmay significantly affect the
quality and consistency of clinical images (lighting, back-
ground color, camera position, equipment calibration and
maintenance, imagemetadata, standardpatientposes, and le-
sionmagnification). Standards for obtaining patient consent,
protecting patient privacywith respect to imageuse, andpre-
ventingunauthorized access topatient images also fallwithin
the scope of standards assigned to this working group. Last,
the Terminology Working Group’s responsibility is to de-
velop a lexicon of standardized terms to describe anatomical
sites, clinical features, dermoscopic characteristics, anddiag-
noses of skin lesions.
Currently, efforts in education and diagnosis regarding
melanoma typically rely on convenience sampling of a lim-
ited number of images that vary in annotation, quality, and
technique. A large public repository of skin images that meet
the standards developed by the ISIC Melanoma Project can
servemultiple communities. Physiciansandeducators canuse
thearchive to improvediagnostic skills, conduct research, and
provideclinical support in the identificationof skin lesions that
display unusual morphological characteristics. The general
public may use the archive for self-education about mela-
noma and the benefits of early detection. Finally, developers
of diagnostic equipment for skin lesions may test new de-
vicesusing thestandard reference images in thearchive.Based
on the aforementioned issues, the second part of the Mela-
nomaProject is designed to establish apublic open-access im-
age archive. Skin lesion images that are to be used only as a
referenceand that are suitable for inclusion in this “Public Skin
Lesion Image Archive” will be annotated using standards de-
fined by the ISIC working groups. In addition, ISIC has suc-
cessfully collaborated with numerous computer program-
mers, including programmers at IBM, on the development of
asetof image-analysis tools (eg, lesionsegmentation)andsemi-
automatedannotationandmark-up tools. These toolswill not
only be useful in the acquisition and annotation of images for
thepublic image archivebutwill serve as benchmarks for oth-
ers who are interested in developing image-analysis pro-
grams for skin lesions.
As is evident in the review by Quigley et al1 in this issue,
there is a glaring lack of standards regarding skin-lesion
imaging.Beforeoutsideagencies impose standardson theder-
matology community, it is imperative thatwe act quickly and
effectively by creating anddefining the imaging standards ap-
propriate for our specialty.
ARTICLE INFORMATION
Author Affiliation:Dermatology Service, Memorial
Sloan Kettering Cancer Center, Hauppauge,
New York.
Group Information:Members of the International
Skin Imaging CollaborationMelanoma Project
Working Groups are listed at the end of this article.
Corresponding Author: Ashfaq A. Marghoob, MD,
Dermatology Service, Memorial Sloan Kettering
Cancer Center, 800 Veterans Memorial Hwy,
Hauppauge, NY 11788 (marghooa@mskcc.org).
Published Online:May 13, 2015.
doi:10.1001/jamadermatol.2015.32.
Conflict of Interest Disclosures:None reported.
The International Skin Imaging Collaboration
(ISIC)MelanomaProjectWorking Groups:
The TechniqueWorking Groupmembers were H.
Peter Soyer, MD, Dermatology Research Centre,
The University of Queensland, School of Medicine,
Translational Research Institute, Brisbane, Australia
(coleader); Clara Curiel, MD, University of Arizona
Cancer Center and Dermatology Section, University
of Arizona, Tucson (coleader); Dennis DaSilva, BS,
Canfield Scientific Inc, Fairfield, New Jersey;
Whitney A. High, MD, JD, MEng, University of
Colorado, Aurora; Lynne H. Morrison, MD, Oregon
Health and Science University, Portland; and Jeb
Zirato, BS, University of Arizona Cancer Center,
Tucson.
The TerminologyWorking Groupmembers were
Harald Kittler, MD,Department of Dermatology,
Medical University of Vienna, Austria (leader);
Giuseppe Argenziano, MD, Arcispedale S. Maria
Nuova, Reggio Emilia, Italy; Ralph P. Braun, MD,
University Hospital of Zurich, Zurich, Switzerland;
Holger Haenssle, MD, University Medical Centre,
Goettingen, Germany; Scott W. Menzies, MD,
University of Sydney at the Sydney Cancer Centre,
Sydney, Australia; Susanna Puig, MD, Hospital Clinic
of Barcelona, Barcelona, Spain; Alon Scope, MD,
ShebaMedical Center and Sackler Faculty of
Medicine, Tel Aviv, Israel; Wilhelm Stolz, MD,
MunichMunicipal Hospital Group, Munich,
Germany; Luc Thomas, MD, PhD, University Claude
Bernard Lyon and Cancer Research Center of Lyon,
Lyon, France; and Iris Zalaudek, MD, Medical
University of Graz, Graz, Austria.
The TechnologyWorking Groupmembers were
JosepMalvehy, MD, Hospital Clinic of Barcelona,
Institut d'Investigacions Biomèdiques August Pi i
Sunyer, and Centro de Investigación Biomédica en
Red de Enfermedades Raras, Barcelona, Spain
(leader); Mani Abedini, PhD, Qiang Chen, PhD, Rahil
Garnavi, PhD, and Xingzhi Sun, PhD, IBM Research
Australia, Melbourne; Doug Canfield, BS, Canfield
Scientific Inc, Fairfield, New Jersey; Noel C. F.
Codella, PhD, IBM T.J. Watson Research Center,
Yorktown Heights, New York; Rafael Garcia, PhD,
and Josep Quintana, PhD, University of Girona,
Spain; Constantino Grana, PhD, and Giovanni
Pellacani, MD, University of Modena and Reggio
Emilia, Modena, Italy; Miron Josipovic, Derma
Medical Systems, Vienna, Austria; Peter Klar,
Visiomed AG, Bielefeld, Germany; Andreas Mayer,
FotoFinder Systems, Inc, Bad Birnbach, Germany;
Scott W. Menzies, MD, University of Sydney at the
Sydney Cancer Centre, Sydney, Australia; Matthew
A. Molenda, MD, ProMedica, Toledo, Ohio; Nizar
Mullani, BSc, 3GEN, LLC, and TransLite, LLC, Dana
Point, California; Susanna Puig, MD, Hospital Clinic
of Barcelona, Barcelona, Spain; Victor Skladnev,
BSc, MEng, AIMEDICS Pty Ltd, Eveleigh, New South
Wales, Australia; andWilliam V. Stoecker, MD,
University of Missouri Health System, Rolla.
The Image Archive member was Rainer Hoffman-
Wellenhof, MD, Department of Dermatology,
Research Centre for Teledermatology, Prevention
and New Innovative Diagnostic Procedures in
Opinion Editorial
820 JAMADermatology August 2015 Volume 151, Number 8 (Reprinted) jamadermatology.com
Downloaded From:  by a Universidad de Barcelona User  on 01/10/2018
Copyright 2015 American Medical Association. All rights reserved.
Dermato-Oncology, Medical University of Graz,
Graz, Austria (director).
Additional Contributions:Drs Soyer and Curiel
contributed to this editorial on behalf of the
TechniqueWorking Group; Dr Kittler, the
TerminologyWorking Group; Dr Malvehy, the
TechnologyWorking Group; and Dr Hoffman-
Wellenhof, the Image Archive. None were
financially compensated.
REFERENCES
1. Quigley EA, Tokay BA, Jewell ST, Marchetti MA,
Halpern AC. Technology and technique standards
for camera-acquired digital dermatologic images:
a clinical review [published online May 13, 2015].
JAMA Dermatol. doi.10.1001/jamadermatol.2015.33.
2. Krupinski E, Burdick A, Pak H, et al. American
Telemedicine Association’s practice guidelines for
teledermatology. Telemed J E Health. 2008;14(3):
289-302.
3. Madden BC. A proposal for Working Group 19:
dermatologic standards: DICOMwhitepaper.
http://medical.nema.org/dicom/minutes/WG-06
/2009/2009-08-24/DICOM-Dermatology
-whitepaper.doc. Published August 14, 2009.
Accessed November 24, 2013.
4. International Health Terminology Standards
Development Organisation.
SNOWMED CT. http://ihtsdo.org/snomed-ct/.
Accessed November 26, 2014.
5. Publications and standards. Institute of Electrical
and Electronics Engineers (IEEE) website. https:
//www.ieee.org/publications_standards/index.html.
Accessed November 26, 2014.
6. Studies. International Dermoscopy Society
website. http://www.dermoscopy-ids.org/index.php
/studies. Accessed November 26, 2014.
7. ISIC: Melanoma Project. International Society for
Digital Imaging of the Skin website. http://www.isdis
.net/index.php/isic-project. AccessedMay 11, 2015.
Erythematotelangiectatic Rosacea
and Telangiectatic Photoaging
Same, Separate, and/or Sequential?
Jonathan K. Wilkin, MD
In 1994, I described rosacea as a cutaneous and ocular vascu-
lar disease,1 which was based on premises the most compel-
ling of which was that patients with severe flushing due to
systemic disease often had
rapidly progressive rosacea,
including ocular rosacea,
facial telangiectasia, and
phymatous changes. The earliest stages of rosacea were pro-
posed to have an inflamed superficial vasculature and low-
grade sterile superficial dermal cellulitis due to recognized
provocative factors, such as local irritants, temperature ex-
tremes, wind, and flushing reactions. Subsequently, I have
sought articles addingmolecular details tomymental picture
of this vascular pathogenesis of rosacea, and the evidentiary
harvest has been abundant.
Steinhoff et al2,3 demonstrated that (1) transient receptor
potential vanilloid subfamily (TRPV) receptors are activated
by typical rosacea trigger factors, such as heat, capsaicin, and
inflammatorymediators, suggesting that flushing from these
trigger factorsmaybeviaTRPV-positivebloodvesselsandmast
cells; (2) erythematotelangiectatic rosacea (ETR), papulopus-
tular rosacea (PPR) and phymatous rosacea may have differ-
entTRPVsubtypeprofiles,with intergrades betweenETRand
PPR suggesting the possibility of a “march” in some patients
with ETR toward PPR; and (3) pituitary adenylate cyclase–
activatingpolypeptide, apotent vasodilator, is upregulated20
to 30 times in early ETR. Clearly, inflammatory rosacea can-
not stand as a synonym exclusively for PPR, given this evi-
dence for inflammatory events in ETR.
Another factorpostulated topossiblycontribute to thevas-
cular pathogenesis of rosacea was actinic damage,1 especially
to theelastinnetworkas a low-resistancepathway through the
interstitium along which macromolecules pass to the lym-
phatic system.4,5 Actinic damage heremight lead to low-grade
superficialdermal lymphatic failure in therosaceadistribution.1
Moreover,photodistributed,mostlyvasodilatordrug–relatedtel-
angiectasia underscores the potential role for actinic exposure
in the pathogenesis of telangiectasia.6 Yano et al7 andKajiya et
al,8 in exploring the mechanisms of acute UV-B–induced an-
giogenesis andphotodamage inhumanskin,demonstrated the
consequent epidermal hyperplasia, infiltration of elastin-
producing neutrophils, and elastin fiber damage, along with a
significant increase inbothvasculardensityandvessel size, fea-
turesconsistentwith theproposedpathogenesisofETR1aswell
as the cutaneous signsof telangiectatic photoaging (TP), asde-
scribed by Helfrich et al.9 There are now plausible molecular
links for clinically well-recognized rosacea triggers, including
actinicdamage,withtheproposedinflammatoryvascularpatho-
genesis of rosacea, beginning with ETR.1
However, not everyone agrees that rosacea begins with
ETR or that ETR is even a subtype of rosacea. Helfrich et al9
remind us that ETR is probably themost disputed subtype of
rosacea,withsomeauthorsarguing that it ismerelyphotodam-
ageor, at least, difficult todistinguish fromphotodamage.This
is a curious twist given that rosacea was first recognized as a
distinct facial dermatosis separate from common acne (acne
vulgaris) by virtue of its rosy hue (acne rosacea).10 Helfrich et
al find that ETR is, in fact, distinguishable from TP.
This study by Helfrich et al9 is pharmacotherapeutically
timely, given the current state of drug product development
forETR.Perhaps their distinctionbetweenETRandTPwill en-
able the physician to better pair treatmentswith specific der-
matoses. Even in the era before the approval of drug prod-
ucts forETR, identificationof erythemaand telangiectasiahad
a role. The occasional patientwould have dramatic reduction
in facial erythema when given systemic antibiotic and anti-
flushing therapy. Among this minority, fewer still would ex-
perience PERT (posterythema-revealed telangiectasia),1 the
emergence of preexisting telangiectasia from a receding
intense erythema.
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